Published Scientific Articles
Concarlo in the News
Many startups are built off research, so why don’t more scientists become founders?
CDK Inhibitors: Why Women – and Men – Should Know About This ‘New Era’ Of Cancer Treatment
Breast Cancer Deserves More Than A Month
Life Sciences Review special edition on BioTech Startup 2022
Webinars & Talks
Case Study: Developing liposomal formulation of a novel 91-mer synthetic peptide for treatment of ER+ CDK4i resistant Breast Cancer
The academic to founder pipeline with Dr. Stacy Blain from Concarlo Therapeutics
Targeting p27Kip1 to Treat Drug-Resistance Cancer
The Cancer Moonshot: A 5 Year Review